Metformin‐Associated Lactic Acidosis During Docetaxel Therapy for Castration‐Resistant Prostate Cancer: A Case Report

Metformin‐Associated Lactic Acidosis During Docetaxel Therapy for Castration‐Resistant Prostate Cancer: A Case Report

ABSTRACT Introduction Docetaxel is a key treatment for castration‐resistant prostate cancer and is administered with prednisolone, which increases the risk of steroid‐induced diabetes. Its myelosuppressive effect also increases vulnerability to febrile neutropenia. Metformin is widely used for glyce...

Full description

Saved in:
Bibliographic Details
Main Authors: Y. Inoue, A. Niimi, T. Kudo, U. Yoshizaki, Y. Sato, H. Kume
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:IJU Case Reports
Subjects:
castration‐resistant prostate cancer
chemotherapy
metformin‐associated lactic acidosis
patient education
sick‐day management
Online Access:https://doi.org/10.1002/iju5.70055
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items